Concepedia
Statistics
Publications
1
Citations
91
H-Index
Active since
2019
J.C. Park is an author specializing in checkpoint antagonist therapy, molecular oncology, and cervical cancer.
Publications per year
2019–2019
Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358
R. Wendel Naumann, Ana Oaknin, Tim Meyer et al. · Annals of Oncology · 2019 · 91 citations · Full text
Medicine, Oncology, Pharmacology +14
1–1 of 1